Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Your search for Obstructive Sleep Apnea returned no results
Showing 31 to 44 of 44 results for obstructive sleep apnoea

  1. In moderate OSAHS, which clinical and physiological phenotypes predict treatment response to customised mandibular advancement splints?

    Source guidance details Comes from guidance Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over

  2. Mandibular advancement splints for severe OSAHS: What is the clinical and cost effectiveness of mandibular advancement splints for managing severe OSAHS?

    Source guidance details Comes from guidance Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over

  3. Oxygen therapy for OSAHS: What is the clinical and cost effectiveness of nocturnal oxygen compared with placebo in people with OSAHS who are unable to tolerate CPAP?

    Source guidance details Comes from guidance Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over

  4. Mandibular advancement splints for mild symptomatic OSAHS and moderate OSAHS: In mild symptomatic OSAHS, which clinical and physiological phenotypes predict treatment response to customised mandibular advancement splints?

    Source guidance details Comes from guidance Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over

  5. Upper airway surgery in people unable to tolerate or adhere to CPAP: What is the clinical and cost effectiveness of upper airway surgical interventions for people with OSAHS who are unable to tolerate or adhere to CPAP?

    Source guidance details Comes from guidance Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over

  6. Treatment for people with COPD–OSAHS overlap syndrome: What is the optimal treatment for people with COPD–OSAHS overlap syndrome: non-invasive ventilation or CPAP?

    Source guidance details Comes from guidance Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over

  7. What is the clinical and cost effectiveness of auto- and fixed-level continuous positive airway pressure (CPAP) for managing moderate and severe OSAHS?

    Source guidance details Comes from guidance Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over

  8. Tonsillectomy using ultrasonic scalpel (IPG178)

    Evidence-based recommendations on tonsillectomy using ultrasonic scalpel. This involves using high-energy waves to cut the tonsils out and stop the bleeding at the same time.

  9. Caesarean birth (NG192)

    This guideline covers when to offer and discuss caesarean birth, procedural aspects of the operation, and care after caesarean birth. It aims to improve the consistency and quality of care for women and pregnant people who are thinking about having a caesarean birth or have had a caesarean birth in the past and are now pregnant again.

  10. Research recommendations

    pneumonia and type I respiratory failure without a history of chronic obstructive pulmonary disease? CG191/3

  11. Community pharmacies: promoting health and wellbeing (NG102)

    This guideline covers how community pharmacies can help maintain and improve people’s physical and mental health and wellbeing, including people with a long-term condition. It aims to encourage more people to use community pharmacies by integrating them within existing health and care pathways and ensuring they offer standard services and a consistent approach. It requires a collaborative approach from individual pharmacies and their representatives, local authorities and other commissioners.

  12. Consultation on NHS England proposals for a phased launch of obesity injection

    Proposals for a phased launch of the obesity injection tirzepatide have been set out, as a consultation begins.

  13. Home testing devices could increase the number of people diagnosed with sleep apnoea

    Five home-testing devices to diagnose a silent sleep condition harming the health of an estimated 2.5 million adults have been recommended by NICE in draft guidance.

  14. NICE recommended weight-loss drug to be made available in specialist NHS services

    Thousands of people will soon be able to be prescribed a drug to help them lose weight as part of their treatment in an NHS specialist weight management service.